ILSI-Biomed Israel

EnzySurge Receives FDA Approval for SilverStream™ Innovative Wound Management Solution

A novel therapeutic method, which can be used for the treatment of pressure ulcers, diabetic ulcers, post-surgical wounds and first and second degree burns, has received the FDA clearance Rosh Ha’Ayin, Israel, December 15, 2009 – EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for the advanced chronic wound management market, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market  its new SilverStream™ solution for prescri...